Not logged in Share Save
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy Cheng, Alice Y. Y.; Mauricio, Didac; Ritzel, Robert; Al-Sofiani, Mohammed E.; Bailey, Timothy; Mabunay, Maria Aileen; Bonnemaire, Mireille; Melas-Melt, Lydie; Mimouni, Safia; Davies, Melanie Share Save
Share Save
Comparative efficacy and safety of Gla-300 versus IDegAsp in insulin-naive people with type 2 diabetes mellitus uncontrolled on oral anti-diabetics Ritzel, Robert; Ghosh, Sujoy; Emral, Rifat; Malek, Rachid; Zeng, Longyi; Mabunay, Maria Aileen; Landgraf, Wolfgang; Guyot, Patricia; Serafini, Paul; Pushkarna, Divya; Malik, Rayaz A. A. Share Save
Share Save
Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM Ritzel, R.; Ghosh, S.; Emral, R.; Malek, R.; Malik, R.; Zeng, L.; Huang, Y.; Mabunay, M. A.; Landgraf, W.; Guyot, P.; Schenk, E.; Pushkarna, D. Share Save
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study Cheng, Alice; Harris, Stewart; Giorgino, Francesco; Seufert, Jochen; Ritzel, Robert; Khunti, Kamlesh; Lauand, Felipe; Melas-Melt, Lydie; Westerbacka, Jukka; Bosnyak, Zsolt; Rosenstock, Julio Share Save
Share Save
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial Rosenstock, Julio; Cheng, Alice; Ritzel, Robert; Bosnyak, Zsolt; Devisme, Christine; Cali, Anna M. G.; Sieber, Jochen; Stella, Peter; Wang, Xiangling; Frias, Juan P.; Roussel, Ronan; Bolli, Geremia B. Share Save
Self- vs. Physician-Led Titration of Insulin Glargine 300 U/mL (Gla-300)-Improved or Comparable Efficacy at Week 24 without Increased Risk of Hypoglycemia, Irrespective of Age (<65 or=65 Years)-TAKE CONTROL Strojek, Krzysztof; Bigot, Gregory; Bonnemaire, Mireille; Delgado, Elias; Donicova, Viera; Kvapil, Milan; Papanas, Nikolaos; Popescu, Luiza; Ritzel, Robert; Schultes, Bernd; Duvnjak, Lea Share Save
Similar Glycemic Control and Less or Comparable Hypoglycemia with Insulin Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (IDeg-100) in Insulin-Naive T2DM on Antihyperglycemic Drugs ± GLP-1 RAs-The BRIGHT Randomized Study Cheng, Alice Y. Y.; Rosenstock, Julio; Ritzel, Robert; Bosnyak, Zsolt; Devisme, Christine; Stella, Peter; Cali, Anna M.; Wang, Xiangling; Frias, Juan P.; Roussel, Ronan; Bolli, Geremia B. Share Save
Impact of Background Antihyperglycemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs. Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naive People with T2DM from the BRIGHT Randomized Study Roussel, Ronan; Rosenstock, Julio; Pettus, Jeremy; Ritzel, Robert; Cheng, Alice; Bosnyak, Zsolt; Devisme, Christine; Cali, Anna M.; Wang, Xiangling; Bolli, Geremia B. Share Save
Share Save
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study Ritzel, Robert; Harris, Stewart B.; Baron, Helen; Florez, Hermes; Roussel, Ronan; Espinasse, Melanie; Muehlen-Bartmer, Isabel; Zhang, Nianxian; Bertolini, Monica; Brulle-Wohlhueter, Claire; Munshi, Medha; Bolli, Geremia B. Share Save
Share Save
Share Save
Share Save
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc Bock, Fabian; Shahzad, Khurrum; Wang, Hongjie; Stoyanov, Stoyan; Wolter, Juliane; Dong, Wei; Pelicci, Pier Giuseppe; Kashif, Muhammed; Ranjan, Satish; Schmidt, Simone; Ritzel, Robert; Schwenger, Vedat; Reymann, Klaus G.; Esmon, Charles T.; Madhusudhan, Thati; Nawroth, Peter P.; Isermann, Berend Share Save
Share Save